Igenica

Develops antibody-based cancer medicines

placeBurlingame, California, United States calendar_todayFounded 2009 groups1 employees language igenica.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 755 times.

YearFilings
20132
20143
20152
20171

Investor mix

6 investors on record; lead investors include The Column Group, Orbimed, 5AM Ventures, Third Rock Ventures.

Investor typeCountShare
Venture capital467%
Other / undisclosed233%
Coming soon